Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide

Research output: Contribution to journalLetterResearchpeer-review

  • D. Bengtsson
  • H. D. Schrøder
  • K. Berinder
  • D. Maiter
  • C. Hoybye
  • O. Ragnarsson
  • Feldt-Rasmussen, Ulla
  • Rasmussen Krogh Rasmussen
  • A. van der Lely
  • M. Petersson
  • G. Johannsson
  • M. Andersen
  • P. Burman
Original languageEnglish
JournalEndocrine
Volume62
Issue number3
Pages (from-to)737-739
Number of pages3
ISSN1355-008X
DOIs
Publication statusPublished - 2018

ID: 217656455